COAG (Hemab Therapeutics Holdings, Inc. Common Stock) Stock Analysis
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) is a publicly traded the market company. As of May 21, 2026, COAG trades at $26.53 with a market cap of $1.27B and a P/E ratio of 0.00. COAG moved +2.40% today. Year to date, COAG is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $23.00 to $36.61. Rallies surfaces COAG's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the latest COAG stock research?
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. COAG moved +2.40% today.
COAG Key Metrics
Key financial metrics for COAG
Metric
Value
Price
$26.53
Market Cap
$1.27B
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$36.61
52-Week Low
$23.00
Volume
183
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Recent COAG Insider Trades
RA CAPITAL MANAGEMENT, L.P. bought 6.39K (~$159.04K) on May 12, 2026.
RA CAPITAL MANAGEMENT, L.P. bought 14.15K (~$346.23K) on May 11, 2026.
RA CAPITAL MANAGEMENT, L.P. bought 25.72K (~$643.00K) on May 11, 2026.
COAG Analyst Consensus
COAG analyst coverage data. Average price target: $0.00.
Common questions about COAG
What can I research for COAG on Rallies?
Hemab Therapeutics Holdings, Inc. Common Stock (COAG) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. COAG moved +2.40% today.
Does Rallies show live market data for COAG?
Rallies combines live market context with ticker research for COAG, including charts, news, financials, analyst data, institutional holdings, politician trades, insider activity, and AI research where available.
